Suppr超能文献

向日葵胰蛋白酶抑制剂-1

Sunflower trypsin inhibitor-1.

作者信息

Korsinczky Michael L J, Schirra Horst Joachim, Craik David J

机构信息

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia.

出版信息

Curr Protein Pept Sci. 2004 Oct;5(5):351-64. doi: 10.2174/1389203043379594.

Abstract

SFTI-1 is a bicyclic 14 amino acid peptide that was originally isolated from the seeds of the sunflower Helianthus annuus. It is a potent inhibitor of trypsin, with a sub-nanomolar K(i) value and is homologous to the active site region of the well-known family of serine protease inhibitors known as the Bowman-Birk trypsin inhibitors. It has a cyclic backbone that is cross-braced by a single disulfide bridge and a network of hydrogen bonds that result in a well-defined structure. SFTI-1 is amenable to chemical synthesis, allowing for the creation of synthetic variants. Alterations to the structure such as linearising the backbone or removing the disulfide bridge do not reduce the potency of SFTI-1 significantly, and minimising the peptide to as few as nine residues results in only a small decrease in reactivity. The creation of linear variants of SFTI-1 also provides a tool for investigating putative linear precursor peptides. The mechanism of biosynthesis of SFTI-1 is not yet known but it seems likely that it is a gene-coded product that has arisen from a precursor protein that may be evolutionarily related to classic Bowman-Birk inhibitors.

摘要

SFTI-1是一种双环14氨基酸肽,最初从向日葵种子中分离得到。它是一种有效的胰蛋白酶抑制剂,解离常数(K(i))值低于纳摩尔,与著名的丝氨酸蛋白酶抑制剂家族Bowman-Birk胰蛋白酶抑制剂的活性位点区域同源。它具有由单个二硫键交叉支撑的环状骨架和导致明确结构的氢键网络。SFTI-1适合化学合成,可用于创建合成变体。对结构的改变,如使骨架线性化或去除二硫键,不会显著降低SFTI-1的效力,将肽最小化至仅九个残基只会导致反应性略有下降。SFTI-1线性变体的产生也为研究假定的线性前体肽提供了一种工具。SFTI-1的生物合成机制尚不清楚,但它似乎可能是一种基因编码产物,源自可能与经典Bowman-Birk抑制剂在进化上相关的前体蛋白。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验